Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-15T04:10:01.568Z Has data issue: false hasContentIssue false
  • English
  • Français

The Changing Epidemiology of Vancomycin-Resistant Enterococci

Published online by Cambridge University Press:  02 January 2015

Kwan Kew Lai,
Sally A. Fontecchio,
Anita L. Kelley,
Stephen Baker and
Zita S. Melvin
Kwan Kew Lai*
Affiliation:
University of Massachusetts Medical School, Department of Medicine, Division of Infectious Diseases and Immunology, Worcester, Massachusetts
Sally A. Fontecchio
Affiliation:
Infection Control Department, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts
Anita L. Kelley
Affiliation:
Infection Control Department, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts
Stephen Baker
Affiliation:
Graduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, Massachusetts
Zita S. Melvin
Affiliation:
Infection Control Department, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts
*
University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655
Get accessRights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the distribution of vancomycin-resistant enterococci (VRE) cases in our hospital and those from outside of our hospital from 1993 through 1998.

Methods:

Weekly rectal surveillance was instituted whenever there were two or more cases present in the units. Cases were divided into acquired in our hospital, acquired outside of our hospital (VRE positive after and within 72 hours of admission, respectively), and indeterminate. Hospital cases were attributed to the originating ward or intensive care unit (ICU) if patients were noted to be positive within 72 hours of transfer.

Results:

From 1993 to 1998, the rate of VRE per 1,000 admissions increased threefold, from 3.2 to 9.8, for the hospital. VRE cases acquired outside of the hospital increased by approximately 5% per year (r = 0.87; P = .03). The rate of VRE per 1,000 admissions increased 1.7-fold in the ICUs and 3.6-fold in the wards. The ICUs had an average of 75.3 cases per year, with the number of new cases per year increasing by approximately 9 (r = 0.80; P = .028). In the wards, there were an average of 22.0 new cases per year, with a slight upward trend of 3 additional new cases per year (r = 0.69; P = .64). There was a highly significant increasing linear trend (P = .0007) for VRE colonization and infection.

Conclusion:

Although VRE still predominate in the ICUs, cases originating from outside of our hospital and the wards are becoming more common. VRE colonization remained more frequent than infection.

Information

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 24 , Issue 4 , April 2003, pp. 264 - 268
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Leclerq, R, Derlot, E, Duval, J, Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157–161.Google Scholar
2.Uttley, AHC, George, RC, Naidoo, J, et al. High-level vancomycin-resistant enterococci causing hospital infection. Epidemiol Infect 1989;103:173–181.Google Scholar
3.Huycke, MM, Sahm, DF, Gilmore, MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis 1998;4:239–249.Google Scholar
4.Marrone, WJ. Vancomycin-resistant enterococci: an update. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20,1995; San Francisco, CA.Google Scholar
5.Ostrowsky, BE, Trick, WE, Sohn, AH, et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001:344;1427–1433.Google Scholar
6.Trick, WE, Kuehnert, MJ, Quirk, SB, et al. Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 1999;180:391–396.Google Scholar
7.National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grew Aerobically, 3rd ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.Google Scholar
8.National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 5th ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.Google Scholar
9.Woods, GL, Washington, JA. Antibacterial susceptibility tests: dilution and disk diffusion. In: Murray, PR, Baron, EJ, Pfaller, MA, Tenover, FC, Yolen, RH, eds. Manual of Clinical Microbiology, 6th ed. Washington, DC: American Society of Microbiology; 1995:1327–1341.Google Scholar
10.Chow, JW, Kuritza, A, Shlaes, DM, Green, M, Sahm, DF, Zervos, MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 1993;31:1609–1611.Google Scholar
11.Cohen, SH, Morita, MM, Bradford, M. A seven-year experience with methicillin resistant Staphylococcus aureus. Am J Med 1991;91(suppl 3B):233S–237S.Google Scholar
12.Jarvis, WR, Thornsberry, C, Boyce, J, Hughes, JM. Methicillin-resistant Staphylococcus aureus at children's hospitals in the United States. Pediatr Infect Dis 1985;4:651–655.Google Scholar
13.Boyce, JM, Causey, WA. Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control 1982;3:377–383.Google Scholar
14.Lai, KK, Fontecchio, SA, Kelley, AL, Melvin, ZS. The epidemiology of fecal carriage of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18:762–765.Google Scholar
15.Linden, P, Pasculle, AW, Kramer, DJ, Kusne, S, Manez, R. The duration of fecal carriage of vancomycin-resistant Enterococcus faecium (VREF). Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 4-7, 1994; Orlando, FL. Abstract J150.Google Scholar
16.Polish, L, Hebden, J, Shay, D, Jarvis, W, Schwalbe, R, Morris, JG Jr. Duration of fecal carriage of vancomycin-resistant enterococcus (VRE) in ICU patients. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1995; San Francisco, CA. Abstract J37.Google Scholar
17.Henning, K, Boone, JN, Brown, AK, Wollner, N, DeLencastre, H, Armstrong, D. Stool surveillance for vancomycin-resistant Enterococcus faecium (VREF) on a pediatric oncology ward: duration of shedding and incidence of clinical infections. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20,1995; San Francisco, CA. Abstract J38.Google Scholar
18.Montecalvo, MA, de Lencastre, H, Carraher, M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680–685.Google Scholar
19.Bonten, MJM, Slaughter, S, Ambergen, AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127–1132.Google Scholar
20.Morris, JG Jr, Shay, DK, Hebden, JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann intern Med 1995;123:250–259.Google Scholar
21.Donskey, CJ, Chowdhry, TK, Hecker, MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:1925–1932.Google Scholar